The Medical Oncology Unit is a clinical service incorporating a research program that provides coordinated multidisciplinary care for patients with a wide range of malignancies.
The unit conducts clinical trials investigating new drug therapies such as targeted systemic treatments and chemotherapy in patients with malignancy. The main areas of research are in malignant melanoma and gastrointestinal malignancies.
In 2014 the unit continued to contribute to both national and international research projects, as well as phase 1, 2 and 3 clinical trials.
An evaluation of the outcomes of patients who achieved complete pathological responses to neo-adjuvant chemoradiotherapy for rectal cancer led us to change our practice to not routinely recommending post-operative chemotherapy to rectal cancer patients.
Surveillance imaging with FDG-PET/CT in the post-operative follow-up of stage 3 melanoma
Lewin J, Sayers L, Kee D, Walpole I, Sanelli A, Te Marvelde L, Herschtal A, Spillane J, Gyorki D, Speakman D, Estall V, Donahoe S, Pohl M, Pope K, Chua M, Sandhu S, McArthur GA, McCormack CJ, Henderson M, Hicks RJ, Shackleton M